Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Deferred Offering Costs

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Deferred Offering Costs

Co-Diagnostics, Inc. (CODX) had Deferred Offering Costs of $347.58 thousand as of 2020-03-02, per its 10-Q filed 2020-11-16.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:DeferredOfferingCosts · last filed 2020-11-16

  • 2020-03-02: Deferred Offering Costs $347.58K.
  • 2020-02-13: Deferred Offering Costs $627.44K.
  • 2020-01-28: Deferred Offering Costs $482.90K.
  • 2019-02-04: Deferred Offering Costs $592.76K.
Period endDeferred Offering Costs
2020-03-02$347.58K
10-Q · filed 2020-11-16
2020-02-13$627.44K
10-Q · filed 2020-11-16
2020-01-28$482.90K
10-Q · filed 2020-11-16
2019-02-04$592.76K
10-Q/A · filed 2020-11-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01